Star Wars: Knights of the Old Republic

The Force Is Strong With Star Wars Jedi: Fallen Order™

Retrieved on: 
Tuesday, November 26, 2019
Online, Entertainment, Mobile Entertainment, Film & Motion Pictures, Family, Consumer electronics, Consumer, Technology, Teens, TV and Radio, Other Consumer, Audio, Video, Electronic Games, Creative works, Video games, Fiction, Electronic Arts games, Windows games, First-person shooters, Multiplayer online games, Third-person shooters, Star Wars, Jedi, Star Wars: Jedi Knight, Star Wars: Knights of the Old Republic

View the full release here: https://www.businesswire.com/news/home/20191126005302/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191126005302/en/
    Star Wars Jedi: Fallen Order is a critical success as well as being the highest rated Star Wars game of this console generation.
  • Business Insider exclaims that Star Wars Jedi: Fallen Order is the best Star Wars game ever made, while GameSpot calls it one of the most compelling game additions to the Star Wars franchise in years.
  • "Star Wars Jedi: Fallen Order demonstrates the amazing potential for original storytelling in Star Wars games, said Sean Shoptaw, SVP, Games and Interactive Experiences, Disney Parks, Experiences and Products.
  • With the fantastic reception and launch so far, Star Wars Jedi: Fallen Order has proven to be the must-play game this Holiday.

TARIS Appoints Tony Kingsley as President and Chief Executive Officer

Retrieved on: 
Thursday, January 3, 2019
RTT, Surgery, Urinary bladder disorders, Medicine, Urology, Overactive bladder, Urinary bladder, Taris, Bladder cancer, Star Wars: Knights of the Old Republic, Kingsley, Health care

LEXINGTON, Mass., Jan. 3, 2019 /PRNewswire/ --TARIS Bio, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today that Tony Kingsley has joined the company as president and chief executive officer and was elected to the TARIS board of directors.

Key Points: 
  • LEXINGTON, Mass., Jan. 3, 2019 /PRNewswire/ --TARIS Bio, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today that Tony Kingsley has joined the company as president and chief executive officer and was elected to the TARIS board of directors.
  • "Sarma and the team have made terrific progress in leveraging their deep knowledge of epithelial bladder biology to design multiple product candidates and securing compelling clinical data for both of our programs in bladder cancer and overactive bladder," said Tony Kingsley, President and Chief Executive Officer of TARIS.
  • Mr. Kingsley comes to TARIS with nearly three decades of biotechnology, pharmaceutical and medical device industry experience.
  • TARIS' lead programs in bladder cancer and overactive bladder position the company to improve patient health and redefine urologic care.